Our cookies

We use cookies, which are small text files, to improve your experience on our website.
You can allow or reject non essential cookies or manage them individually.

Reject allAllow all

More options  •  Cookie policy

Our cookies

Allow all

We use cookies, which are small text files, to improve your experience on our website. You can allow all or manage them individually.

You can find out more on our cookie page at any time.

EssentialThese cookies are needed for essential functions such as logging in and making payments. Standard cookies can't be switched off and they don't store any of your information.
AnalyticsThese cookies help us collect information such as how many people are using our site or which pages are popular to help us improve customer experience. Switching off these cookies will reduce our ability to gather information to improve the experience.
FunctionalThese cookies are related to features that make your experience better. They enable basic functions such as social media sharing. Switching off these cookies will mean that areas of our website can't work properly.
AdvertisingThese cookies help us to learn what you're interested in so we can show you relevant adverts on other websites and track the effectiveness of our advertising.
PersonalisationThese cookies help us to learn what you're interested in so we can show you relevant content.

Save preferences

Committees

HEART UK is supported by experts who guide and advise various aspects of our work. 

Medical, Scientific and Research Committee

Chaired by Dr Handrean Soran, Consultant Physician & Endocrinologist, Department of Medicine, Manchester University Hospitals NHS Foundation Trust

Oversee the Annual Conference, the development of research and speciality training programmes,  allocation of research awards and clinical guideline development

HEART UK's CVD Collaborative

Chaired by Jules Payne, Chief Executive

Advises on public affairs and policy activities to highlight the importance of cholesterol and CVD. Membership includes Amgen, Bayer, Daiichi Sankyo and Novartis and an annual membership fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Group’s work. 

HEART UK Primary Care Education Programme Advisory Group

Chaired by Jules Payne, Chief Executive

Advises on the development and implementation of an education programme for primary care healthcare professionals and further the objectives of the charity to provide learning opportunities on lipid management.

Membership includes Boehringer Ingelheim, Novartis and Sanofi and an annual fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Primary Care Education Programme Advisory Group’s work.”

Healthcare Committee

Chaired by Michaela Nuttall, Cardiovascular Nurse Specialist

Provides up-to-date information to health care professionals who care for patients and their families with lipid disorders and co-organise the Annual Conference.

 

Lipid Interest Group

Chaired by Alison Pottle, Nurse Consultant in Cardiology, Harefield Hospital

Education, networking, promoting information and support for people with an interest in lipids i.e. nurses, dieticians across both primary and secondary care.

Lipoprotein Apheresis Working Group

Chaired by Dr Dev Datta, Consultant in Metabolic Medicine, University Hospital of Wales, Cardiff

To promulgate guidance regarding the clinical indications for undertaking lipoprotein apheresis and the criteria of efficacy of its performance in the UK.

Assessment of the latter will be based upon data collected in a Registry, which is set up under the aegis of HEART UK and the Royal College of Physicians.  Also to widen the knowledge about Apheresis as a treatment.

Product Approval Working Group

Evaluates products for approval following an ethical and scientific policy framework.

Simon Broome Steering Committee

Chaired by Dr Nigel Capps, Consultant Chemical Pathologist Shrewsbury and Telford Hospital NHS Trust

Responsible for directing research based on a national cohort of over 3,500 patients and familial hypercholesterolaemia.  The Sub-Committee is composed of clinical academics, geneticists and clinicians.